Regulus Therapeutics Inc (NASDAQ:RGLS)

12.94
Delayed Data
As of 10:40am ET
 +0.19 / +1.49%
Today’s Change
6.08
Today|||52-Week Range
25.60
-19.33%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Astrazeneca Plc
Sale11/12/20142,000,000$17.00$34.0M-35.02%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale3/05/201565,614$20.06$1.3M-39.66%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/28/201572,011$17.97$1.3M-27.80%
Gibson Neil W
Chief Scientific Officer
Sale1/28/201571,345$17.98$1.3M-27.80%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/17/201573,929$16.94$1.3M-26.30%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/20/201566,071$16.85$1.1M-25.79%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/21/201560,000$17.73$1.1M-27.64%
Alnylam Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K-7.27%
Isis Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K-7.27%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/29/201533,773$17.77$600.1K-31.38%
Page of 20

To view my watchlist

Not a member yet?

Sign up now for a free account